Trial intelligence / Profile preview

Fluticasone Propionate/Formoterol Fumarate in COPD

NCT01168310Phase 2Completed

Sponsor
Dey
Start
Aug 2010
Primary completion
Aug 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fluticasone propionate nasal spray in chronic obstructive pulmonary disease (COPD), sponsored by Dey. Started Aug 2010; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01168310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01168310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call